Equity
Exploring how personalised medicine approaches can be made equitable across diverse populations.
The CPM recognises that an important aspect of personalised medicine is that currently the costs and benefits are not equitably distributed globally. Research databases are often significantly skewed towards populations of European ancestry, leading to a poorer understanding of the clinical implications of data across underrepresented populations. Additionally, socioeconomic inequalities are widening, and personalised medicine initiatives may exacerbate this, as many populations that already experience worse health outcomes are often also underrepresented in research databases.
The CPM is exploring considerations of equity in personalised medicine through the lens of the CPM’s three pillar themes: 1) diagnosis and treatment, 2) risk and prevention, and 3) evolving health system boundaries.
